
-
- Medicines
Flexible solutions for development and local production of complex drugs for serious and rare diseases are an important factor in public health
Rentschler Biopharma expands production of highly complex antibodies at German site
- Manufacturing capacity for biopharmaceuticals is important benchmark for Germany as a biotechnology location, according to yesterday’s Biotech Report published by vfa bio and Boston Consulting Group
- Rentschler Biopharma expands production capacity with 2,000-liter bioreactor to address increasing…